The Harvard Drug Group LLC recalls Midodrine Hydrochloride Tablets
- Recalling company
- The Harvard Drug Group LLC
- Product
- Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
- Reason
- Defective container; inadequately sealed blister packaging.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Feb 17, 2026
- Reported
- Mar 11, 2026
- Distribution
- Nationwide US.
- Status
- Ongoing
- Quantity
- 8892 cartons
- Lot / codes
- Lot # N02640, Exp Date: 08/2027
- Company location
- Dublin, OH
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0383-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0383-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.